Osteoprotegrin (OPG) Receptor Activator of Nuclear-kappa B (RANK) and RANK Ligand (RANKL):  a Complex Interplay between Breast Cancer Progression and the Bone

Sioned Owen; Andrew J. Sanders; Malcolm D. Mason; Wen G. Jiang

Osteoprotegrin (OPG) Receptor Activator of Nuclear-kappa B (RANK) and RANK Ligand (RANKL): a Complex Interplay between Breast Cancer Progression and the Bone

Sioned Owen, Andrew J. Sanders, Malcolm D. Mason, Wen G. Jiang

Research output: Contribution to journal › Conference or Meeting Abstract › peer-review

Original language	English
Article number	SBO4B05
Pages (from-to)	4311-4312
Number of pages	2
Journal	Anticancer research
Volume	35
Issue number	7
Publication status	Published - Jul 2015
Externally published	Yes
Event	China-United Kingdom Cancer (CUKC) Conference 2015 - National Museum, Cardiff, United Kingdom Duration: 17 Jul 2015 → 18 Jul 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://ar.iiarjournals.org/content/35/7/4283

Cite this

@article{d2c95f4cdd0144eb8e40b213fcd882ad,

title = "Osteoprotegrin (OPG) Receptor Activator of Nuclear-kappa B (RANK) and RANK Ligand (RANKL): a Complex Interplay between Breast Cancer Progression and the Bone ",

author = "Sioned Owen and Sanders, {Andrew J.} and Mason, {Malcolm D.} and Jiang, {Wen G.}",

year = "2015",

month = jul,

language = "English",

volume = "35",

pages = "4311--4312",

journal = "Anticancer research",

issn = "0250-7005",

publisher = "International Institute of Anticancer Research",

number = "7",

note = "China-United Kingdom Cancer (CUKC) Conference 2015 ; Conference date: 17-07-2015 Through 18-07-2015",

}

Osteoprotegrin (OPG) Receptor Activator of Nuclear-kappa B (RANK) and RANK Ligand (RANKL): a Complex Interplay between Breast Cancer Progression and the Bone . / Owen, Sioned; Sanders, Andrew J.; Mason, Malcolm D. et al.
In: Anticancer research, Vol. 35, No. 7, SBO4B05, 07.2015, p. 4311-4312.

Research output: Contribution to journal › Conference or Meeting Abstract › peer-review

TY - JOUR

T1 - Osteoprotegrin (OPG) Receptor Activator of Nuclear-kappa B (RANK) and RANK Ligand (RANKL)

T2 - China-United Kingdom Cancer (CUKC) Conference 2015

AU - Owen, Sioned

AU - Sanders, Andrew J.

AU - Mason, Malcolm D.

AU - Jiang, Wen G.

PY - 2015/7

Y1 - 2015/7

M3 - Conference or Meeting Abstract

SN - 0250-7005

VL - 35

SP - 4311

EP - 4312

JO - Anticancer research

JF - Anticancer research

IS - 7

M1 - SBO4B05

Y2 - 17 July 2015 through 18 July 2015

ER -